IMC Logo.jpg
US DoD Naval Medical Research Center Requests Meeting with FDA for Guidance on two Phase 2 trials to Prevent Acute Infectious Diarrhea
June 09, 2020 06:00 ET | Immuron Limited
Key Points NMRC requests Pre-IND meeting with FDA on the development of a new oral therapeutic targeting Campylobacter and ETEC Two human phase II clinical trials to be conducted in 2021One trial...
IMC Logo.jpg
US Department of Defense Reports Final Results from Travelan® Shigellosis Challenge Study
June 12, 2019 07:00 ET | Immuron Limited
Key Highlights: Travelan® shigellosis challenge studies in non-human primates successfully completedTravelan® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan® treated animals...
IMC Logo.jpg
US Department of Defense Reports Travelan Protects Against Shigella in Primates
September 05, 2018 10:00 ET | Immuron Limited
Key Highlights: Travelan® pre-clinical shigellosis challenge studies in non-human primates (NHP) successfully completedTravelan® prevented clinical shigellosis (bacillary dysentery) in 75% of...
IMC Logo.jpg
US Department of Defense Research Collaboration Moves Forward
July 24, 2018 06:28 ET | Immuron Limited
Key Highlights: Three US Defense Health funded research projects on Travelan® successfully completedStudies commissioned by the US Department of Defense to evaluate Travelan®’s ability to...
IMC Logo.jpg
Immuron’s Travelan® Sales Continue to Soar in Third Quarter of FY2018 in Australian & US Markets
April 23, 2018 09:30 ET | Immuron Limited
Key Highlights: US Travelan® sales continue an upward trend with a 95% increase in the Third Quarter of 2018 compared to the same period last year. YTD US sales (End March 2018) climbed to...
IMC Logo.jpg
US Defense Reports Broad Travelan® Reactivity to 180 Pathogenic Bacteria Including Camylobacter and Shigella
January 29, 2018 09:20 ET | Immuron Limited
Key Highlights: The research program was performed by the U.S. Department of Defense (DoD) and was conducted by the Department of Enteric Diseases, Armed Forces Research Institute of Medical Sciences...
3G-Logo-FullColor.jpg
3Gtms Selected by Crowley Logistics as TMS Provider for Department of Defense Contract
January 10, 2018 10:00 ET | 3Gtms
SHELTON, Conn., Jan. 10, 2018 (GLOBE NEWSWIRE) -- 3Gtms, Inc., a leading provider of Tier 1 transportation management software, announced today that it has been selected by Crowley Logistics Inc., a...
Trans-Africa Airlift Support Contract (TASC) awarded to Erickson in support of U.S. African Operations
March 08, 2017 14:59 ET | Erickson, Incorporated
PORTLAND, Ore., March 08, 2017 (GLOBE NEWSWIRE) -- Erickson Incorporated (the “Company”), a leading global provider of aviation services, is pleased to announce that the United States Transportation...
Former Defense Department Deputy General Counsel of Environment, Energy and Installations Joins WilmerHale WASHINGTON, DC, Dec. 13, 2016 (GLOBE NEWSWIRE) -- Rachel Jacobson, former Deputy General Counsel of Environment, Energy and Installations at the US Department of Defense (DOD), will join WilmerHale....
AbCellera and MassBiologics Partner to Discover Fully Human Antibodies Against Drug-Resistant Bacteria
July 20, 2016 09:00 ET | AbCellera
VANCOUVER, British Columbia, July 20, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...